Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Acq. announced
Appointed director
|
|
INSITE VISION INC (INSV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2015 |
8-K
| Quarterly results |
| 05/12/2015 |
8-K
| Quarterly results |
| 11/05/2014 |
8-K
| Quarterly results |
| 08/13/2014 |
8-K
| Quarterly results |
| 05/14/2014 |
8-K
| Quarterly results |
| 11/12/2013 |
8-K
| Form 8-K - Current report |
| 08/08/2013 |
8-K
| Quarterly results|
Docs:
|
"InSite Vision Reports Second Quarter 2013 Financial Results Alameda, Calif., August 8, 2013 - InSite Vision Incorporated today reported financial results for the quarter ended June 30, 2013. Revenues for the second quarter of 2013 were $19.2 million compared to $1.8 million for the same period in 2012. Included in the second quarter of 2013 were revenues of $15 million for the sale of the Besivance royalty rights. Net income for the second quarter of 2013 was $12.1 million, or $0.09 per share, compared to a net loss of $6.8 million, or $0.05 per share, in the second quarter of 2012. “2013 continues to be a year of dedicated focus for InSite as we work with our clinical investigators and the FDA to advance our pipeline of ophthalmic therapeutics,” said Timothy Ruane, InSite's Chief Executiv..." |
|
| 05/07/2013 |
8-K
| Quarterly results |
| 11/08/2012 |
8-K
| Quarterly results |
| 07/31/2012 |
8-K
| Quarterly results |
| 05/01/2012 |
8-K
| Quarterly results |
| 10/27/2011 |
8-K
| Form 8-K - Current report |
| 08/02/2011 |
8-K
| Form 8-K - Current report |
| 05/12/2011 |
8-K
| Quarterly results |
| 11/04/2010 |
8-K
| Quarterly results |
| 08/05/2010 |
8-K
| Form 8-K - Current report |
| 05/05/2010 |
8-K
| Quarterly results |
| 11/12/2009 |
8-K
| Form 8-K - Current report |
| 08/06/2009 |
8-K
| Form 8-K - Current report |
| 05/11/2009 |
8-K
| Form 8-K -- Current report |
| 11/06/2008 |
8-K
| Quarterly results |
| 08/11/2008 |
8-K
| Quarterly results |
| 05/08/2008 |
8-K
| Quarterly results |
| 11/07/2007 |
8-K
| Quarterly results |
| 08/08/2007 |
8-K
| Quarterly results |
| 05/09/2007 |
8-K
| Quarterly results |
| 11/14/2006 |
8-K
| Quarterly results |
| 08/14/2006 |
8-K
| Quarterly results |
| 05/11/2006 |
8-K
| Quarterly results |
| 11/14/2005 |
8-K
| Quarterly results|
Docs:
|
"InSite Vision Reports Third Quarter 2005 Financial Results; Conference Call to Begin at 10:30 a.m. ET Today ALAMEDA, Calif.--—November 14, 2005--InSite Vision Incorporated an ophthalmic products company currently focused on developing therapies that treat ocular infection, glaucoma, and retinal diseases today reported financial results for the three and nine months ended September 30, 2005. Net loss for the 2005 third quarter was $3.5 million, or $0.04 per share, compared with a net loss of $3.3 million, or $0.05 per share, for the 2004 third quarter. For the nine months ended September 30, 2005, the Company reported a net loss of $11.1 million, or $0.16 per share, compared with net loss of $2.4 million, or $0.06 per share, for the nine months ended September 30, 2004. Research and develop..." |
|
| 08/15/2005 |
8-K
| Quarterly results|
Docs:
|
"InSite Vision Reports Second Quarter 2005 Financial Results; Conference Call to Begin at 9:15 a.m. ET Today ALAMEDA, Calif.---August 15, 2005 -- InSite Vision Incorporated an ophthalmic therapeutics, diagnostics and drug-delivery company today reported financial results for the three and six months ended June 30, 2005. Net loss for the 2005 second quarter was $4.2 million, or $0.06 per share, compared with a net loss of $1.5 million, or $0.04 per share, for the 2004 second quarter. For the six months ended June 30, 2005, the Company reported a net loss of $7.7 million, or $0.11 per share, compared with net income of $0.9 million, or $0.03 per share, for the six months ended June, 30, 2004. Research and development expenses for the second quarter of 2005 were $3.1 million, compared with $1...." |
|
| 05/16/2005 |
8-K
| Quarterly results |
| 11/12/2004 |
8-K
| Quarterly results |
|
|